IKNA
Price
$1.56
Change
-$0.04 (-2.48%)
Updated
Dec 20, 04:59 PM (EDT)
87 days until earnings call
JAZZ
Price
$123.00
Change
+$0.15 (+0.12%)
Updated
Dec 20, 04:59 PM (EDT)
73 days until earnings call
Ad is loading...

IKNA vs JAZZ

Header iconIKNA vs JAZZ Comparison
Open Charts IKNA vs JAZZBanner chart's image
Ikena Oncology
Price$1.56
Change-$0.04 (-2.48%)
Volume$906
CapitalizationN/A
Jazz Pharmaceuticals
Price$123.00
Change+$0.15 (+0.12%)
Volume$25.78K
CapitalizationN/A
IKNA vs JAZZ Comparison Chart
Loading...
IKNA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
JAZZ
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
IKNA vs. JAZZ commentary
Dec 21, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IKNA is a Hold and JAZZ is a Hold.

COMPARISON
Comparison
Dec 21, 2024
Stock price -- (IKNA: $1.56 vs. JAZZ: $123.00)
Brand notoriety: IKNA and JAZZ are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IKNA: 248% vs. JAZZ: 247%
Market capitalization -- IKNA: $75.28M vs. JAZZ: $7.44B
IKNA [@Biotechnology] is valued at $75.28M. JAZZ’s [@Biotechnology] market capitalization is $7.44B. The market cap for tickers in the [@Biotechnology] industry ranges from $464.4B to $0. The average market capitalization across the [@Biotechnology] industry is $2.57B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IKNA’s FA Score shows that 1 FA rating(s) are green whileJAZZ’s FA Score has 0 green FA rating(s).

  • IKNA’s FA Score: 1 green, 4 red.
  • JAZZ’s FA Score: 0 green, 5 red.
According to our system of comparison, JAZZ is a better buy in the long-term than IKNA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IKNA’s TA Score shows that 4 TA indicator(s) are bullish while JAZZ’s TA Score has 4 bullish TA indicator(s).

  • IKNA’s TA Score: 4 bullish, 6 bearish.
  • JAZZ’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, JAZZ is a better buy in the short-term than IKNA.

Price Growth

IKNA (@Biotechnology) experienced а -5.45% price change this week, while JAZZ (@Biotechnology) price change was -0.03% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.20%. For the same industry, the average monthly price growth was -1.27%, and the average quarterly price growth was +2.17%.

Reported Earning Dates

IKNA is expected to report earnings on Mar 18, 2025.

JAZZ is expected to report earnings on Mar 04, 2025.

Industries' Descriptions

@Biotechnology (-2.20% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
JAZZ($7.44B) has a higher market cap than IKNA($75.3M). JAZZ YTD gains are higher at: 0.000 vs. IKNA (-20.812). JAZZ has higher annual earnings (EBITDA): 1.31B vs. IKNA (-63.58M). JAZZ has more cash in the bank: 2.62B vs. IKNA (138M). IKNA has less debt than JAZZ: IKNA (8.39M) vs JAZZ (6.2B). JAZZ has higher revenues than IKNA: JAZZ (3.99B) vs IKNA (659K).
IKNAJAZZIKNA / JAZZ
Capitalization75.3M7.44B1%
EBITDA-63.58M1.31B-5%
Gain YTD-20.8120.000-
P/E RatioN/A17.42-
Revenue659K3.99B0%
Total Cash138M2.62B5%
Total Debt8.39M6.2B0%
FUNDAMENTALS RATINGS
JAZZ: Fundamental Ratings
JAZZ
OUTLOOK RATING
1..100
74
VALUATION
overvalued / fair valued / undervalued
1..100
62
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
62
PRICE GROWTH RATING
1..100
46
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
75

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
IKNAJAZZ
RSI
ODDS (%)
Bullish Trend 1 day ago
90%
Bearish Trend 5 days ago
64%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
90%
Bullish Trend 1 day ago
58%
Momentum
ODDS (%)
Bearish Trend 1 day ago
82%
Bullish Trend 1 day ago
64%
MACD
ODDS (%)
Bearish Trend 4 days ago
74%
Bearish Trend 1 day ago
65%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
84%
Bearish Trend 1 day ago
59%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
85%
Bullish Trend 1 day ago
69%
Advances
ODDS (%)
Bullish Trend about 1 month ago
84%
Bullish Trend 1 day ago
64%
Declines
ODDS (%)
Bearish Trend 6 days ago
86%
Bearish Trend 4 days ago
60%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
88%
Bearish Trend 1 day ago
81%
Aroon
ODDS (%)
Bearish Trend 1 day ago
86%
Bullish Trend 1 day ago
59%
View a ticker or compare two or three
Ad is loading...
IKNA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
JAZZ
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MGRM2.570.06
+2.39%
Monogram Orthopaedics
CFR132.871.59
+1.21%
Cullen/Frost Bankers
TMUS220.312.31
+1.06%
T-Mobile US
THRM38.670.04
+0.12%
Gentherm
GLRE13.90N/A
N/A
Greenlight Capital Re Ltd

IKNA and

Correlation & Price change

A.I.dvisor indicates that over the last year, IKNA has been closely correlated with ABCZF. These tickers have moved in lockstep 72% of the time. This A.I.-generated data suggests there is a high statistical probability that if IKNA jumps, then ABCZF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IKNA
1D Price
Change %
IKNA100%
-3.11%
ABCZF - IKNA
72%
Closely correlated
N/A
ATRA - IKNA
72%
Closely correlated
+14.80%
AMLX - IKNA
54%
Loosely correlated
+2.02%
VNDA - IKNA
37%
Loosely correlated
+3.13%
FATE - IKNA
35%
Loosely correlated
+1.81%
More

JAZZ and

Correlation & Price change

A.I.dvisor indicates that over the last year, JAZZ has been loosely correlated with AMLX. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if JAZZ jumps, then AMLX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To JAZZ
1D Price
Change %
JAZZ100%
+0.12%
AMLX - JAZZ
43%
Loosely correlated
+2.02%
SRPT - JAZZ
35%
Loosely correlated
-0.42%
AXON - JAZZ
34%
Loosely correlated
+2.59%
VCYT - JAZZ
34%
Loosely correlated
+4.66%
NTLA - JAZZ
33%
Loosely correlated
+1.08%
More